On July 21, according to Cansino Biotech, the company reached a cooperation agreement with its Pakistani partner AGP Limited on the 13-valent pneumococcal polysaccharide conjugate vaccine during the Pakistan-China inter-enterprise investment summit. The two sides will further explore the future development opportunities of this product in Pakistan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.